Hologic to go private for up to $18.3B
Funds managed by Blackstone and TPG plan to acquire the medtech firm for up to $79 per share.
Cost Control to Capability Building: Rethinking Supply and Strategy in Pharma
In this episode presented by Element Materials Technology, guests Dr. Jihye Jang-Lee and Dr. Khanh Courtney will explore how healthcare and pharmaceutical players are rethinking their strategies amid global supply chain disruption.
Cost Control to Capability Building: Rethinking Supply and Strategy in Pharma Read More »
Krystal Biotech’s FDA Platform Designation Pushes Limits of the Award
The company’s technology, a modified herpes simplex virus used to deliver gene therapies, was given the FDA’s new designation based on its approved topical skin cream. What this will mean for Krystal’s still-in-development eye drop is unclear.
Krystal Biotech’s FDA Platform Designation Pushes Limits of the Award Read More »
Ascendis Skids as FDA Detects Death in Patient on Yorvipath
The death occurred in a patient who had a complex medical background and who was being managed with several drugs, according to RBC Capital.
Ascendis Skids as FDA Detects Death in Patient on Yorvipath Read More »
Summit Eyes 2025 FDA Application for Ivonescimab Despite Overall Survival Miss
In May, Summit released early data from the Phase III HARMONi study showing that while the PD-1/VEGF inhibitor resulted in significant progression-free survival improvements, it fell short of the overall survival bar.
Summit Eyes 2025 FDA Application for Ivonescimab Despite Overall Survival Miss Read More »
Exelixis’ Kinase Blocker Sets ‘New Survival Bar’ in Third-Line Colorectal Cancer, Opening Road to FDA
With data from the Phase III STELLAR-303 study in the books, Exelixis is plotting a 2025 regulatory application for zanzalintinib.
Galapagos Exits Cell Therapy, Cuts 365 Employees
Galapagos at the start of the year had planned to split into two businesses, with one resulting entity focused on cell therapies. The biotech nixed these plans a few months later, instead choosing to put up for sale multiple cell therapy assets.
Galapagos Exits Cell Therapy, Cuts 365 Employees Read More »
Nuevo y barato sistema para desalinizar agua de mar
La mayor parte del agua de la Tierra está en los océanos y es demasiado salada para poder beberla. Las plantas desalinizadoras pueden potabilizar el agua de mar, pero requieren grandes cantidades de energía. Ahora, unos científicos han desarrollado un material co …
Nuevo y barato sistema para desalinizar agua de mar Read More »
Descubren las claves evolutivas del "motor" de las células
Unos científicos han averiguado cómo ha evolucionado el sistema energético de las células y cómo ese conocimiento puede usarse para entender mejor las enfermedades genéticas y avanzar hacia nuevos tratamientos contra ellas. El estudio lo ha realizad …
Descubren las claves evolutivas del "motor" de las células Read More »
Sir Patrick Moore: El astrónomo amateur que conquistó los cielos y las pantallas
Sir Patrick Alfred Caldwell-Moore (4 de marzo de 1923 ‒ 9 de diciembre de 2012) fue un astrónomo amateur británico cuya pasión por el cosmos y su talento para la divulgación lo convirtieron en una figura icónica de la astronomía contemporánea. Duran …
Sir Patrick Moore: El astrónomo amateur que conquistó los cielos y las pantallas Read More »